The signaling pathway of cardiotrophin-1 is not activated in hypertrophied ventricles of carnitine-deficient juvenile visceral steatosis (JVS) mice

In Vivo

Volumn 14, Issue 3, 2000, Pages 401-405

  Yoshida, Goichiro ^a,b   Horiuchi, Masahisa ^a   Kobayashi, Keiko ^a   Jalil, M D Abdul ^a   Iijima, Mikio ^a   Hagihara, Sumio ^b   Nagao, Naruhiko ^b   Saheki, Takeyori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF FITNESS AND SPORTS IN KANOYA   (Japan)

Author keywords

Cardiac hypertrophy, cardiotrophin 1, carnitine deficiency, juvenile visceral steatosis mice, signal transducer and activator of transcription 3

Indexed keywords

CARDIOTROPHIN 1; CARNITINE; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; SOMATOMEDIN B; SOMATOMEDIN C; STAT3 PROTEIN;

ANIMAL MODEL; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; LIVER; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; STEATOSIS; VISCERA;

EID: 0033932877     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. o strain of mouse with similarities to Reye's syndrome. Lab Anim 22: 83-87, 1988.
2. o mice. Mouse Genome 86: 261, 1990.
3. o mice with juvenile steatosis of viscera. FEBS Lett 260: 119-121, 1990.
4. Kuwajima M, Kono N, Horiuchi M, Imamura Y, Ono A, Inui Y, Kawata S, Koizumi T, Hayakawa J, Saheki T and Tarui S: Animal model of systemic carnitine deficiency: Analysis in C3H-H-2o strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun 174: 1090-1094, 1991.
5. Tomomura M, Imamura Y, Horiuchi M, Koizumi T, Nikaido H, Hayakawa J and Saheki T: Abnormal expression of urea cycle enzyme genes in juvenile visceral steatosis (jvs) mice. Biochim Biophys Acta 1138: 167-171, 1992.
6. Horiuchi M, Kobayashi K, Tomomura M, Kuwajima M, Imamura Y, Koizumi T, Nikaido H, Hayakawa J and Saheki T: Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J Biol Chem 267: 5032-5035, 1992.
7. Horiuchi M, Yoshida H, Kobayashi K, Kuriwaki K, Yoshimine K, Tomomura M, Koizumi T, Nikaido H, Hayakawa J, Kuwajima M and Saheki T: Cardiac hypertrophy in juvenile visceral steatosis (jvs) mice with systemic carnitine deficiency. FEBS Lett 326: 267-271, 1993.
8. Kuwajima M, Lu K, Harashima H, Ono A, Sato I, Mizuno A, Murakami T, Nakajima H, Miyagawa J, Namba M, Hanafusa T, Hayakawa J, Matsuzawa Y and Shima K: Carnitine transport defect in fibroblasts of juvenile visceral steatosis (jvs) mouse. Biochem Biophys Res Commun 223: 283-287, 1996.
9. Nakajima T, Horiuchi M, Yamanaka H, Kizaki Z, Inoue F, Kodo N, Kinugasa A, Saheki T and Sawada T: The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. Pediatr Res 42: 108-113, 1997.
10. Horiuchi M, Kobayashi K, Yamaguchi S, Shimizu N, Koizumi T, Nikaido H, Hayakawa J, Kuwajima J and Saheki T: Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system. Biochim Biophys Acta 1226: 25-30, 1994.
11. Horiuchi M, Kobayashi K, Asaka N and Saheki T: Secondary abnormality of carnitine biosynthesis results from carnitine reabsorptional system defect in juvenile visceral steatosis mice. Biochim Biophys Acta 1362: 263-268, 1998.
12. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y and Tsuji A: Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273: 20378-20382, 1998.
13. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M and Tsuji A: Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21: 91-94, 1999.
14. Treem WR, Stanley CA, Finegold DN, Hale DE and Coates PM: Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med 319: 1331-1336, 1988.
15. Tein I, De Vivo DC, Bierman F, Pulver P, De Meirleir LJ, Cvitanovic-Sojat L, Pagon RA, Bertini E, Dionisi-Vici C, Servidei S and DiMauro S: Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 28: 247-255, 1990.
16. Yoshimine K, Horiuchi M, Suzuki S, Kobayashi K, Abdul JM, Masuda M, Tomomura M, Ogawa Y, Itoh H, Nakao K, Osame M and Saheki T: Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of jvs mice with systemic carnitine deficiency. J Mol Cell Cardiol 29: 571-578, 1997.
17. Jalil A, Horiuchi M, Nomoto M, Kobayashi K and Saheki T: Catecholamine metabolism inhibitors and receptor blockades only partially suppress cardiac hypertrophy of juvenile visceral steatosis mice with systemic carnitine deficiency. Life Sci 64: 1137-1144, 1999.
18. Izumo S, Lompré A-M, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B and Mahdavi V: Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 79: 970-977, 1987.
19. Dorn GW II, Robbins J, Ball N and Walsh RA: Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol 267: H400-405, 1994.
20. Kanda T, Nakano M, Arai M, Yamamoto A, Suzuki T and Murata K: Myocardial atrial natriuretic factor gene expression after coronary ligation in rats. Exp Clin Endocrinol 101: 173-177, 1993.
21. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh S-M, Darbonne WC, Knutzon DS, Yen R, Chien KR, Baker JB and Wood WI: Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 92: 1142-1146, 1995.
22. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI and Chien KR: Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. J Biol Chem 271: 9535-9545, 1996.
23. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF and Wood WI: Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 270: 10915-10922, 1995.
24. Sheng Z, Pennica D, Wood WI ,and Chien KR: Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122: 419-428, 1996.
25. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH and Chien KR: Cardiotrophin-1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 272: 5783-5791, 1997.
26. Ishikawa M, Saito Y, Miyamoto Y, Kuwahara K, Ogawa E, Nakagawa O, Harada M, Masuda I and Nakao K: cDNA cloning of rat cardiotrophin-1 (CT-1): augmented expression of CT-1 gene in ventricle of genetically hypertensive rats. Biochem Biophys Res Commun 219: 377-381, 1996.
27. Ishikawa M, Saito Y, Miyamoto Y, Nakagawa O, Kuwahara K, Ogawa E, Harada M, Masuda I and Nakao K: Augmented expression of cardiotrophin-1 mRNA in the ventricle of genetically hypertensive rats (SHRSP/Izm). Jpn Heart J 38: 586, 1997.
28. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR and Catanese VM: Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 89: 799-809, 1994.
29. Hanson MC, Fath KA, Alexander RW and Delafontaine P: Induction of cardiac insulin-like growth factor I gene expression in pressure overload hypertrophy. Am J Med Sci 306: 69-74, 1993.
30. Engelmann GL, Campbell SE and Rakusan K: Immediate postnatal rat heart development modified by abdominal aortic banding: analysis of gene expression. Mol Cell Biochem 163-164: 47-56, 1996.
31. Masuda M, Kobayashi K, Horiuchi M, Terazono H, Yoshimura N and Saheki T: A novel gene suppressed in the ventricle of carnitine-deficient juvenile visceral steatosis mice. FEBS Lett 408: 221-224, 1997.
32. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
33. Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A and Metcalf D: Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J 6: 3995-4002, 1987.
34. Telford NA, Hogan A, Franz CR and Schultz GA: Expression of genes for insulin and insulin-like growth factors and receptors in early postimplantation mouse embryos and embryonal carcinoma cells. Mol Reprod Dev 27: 81-92, 1990.
35. Alonso S, Minty A, Bourlet Y and Buckingham M: Comparison of three actin-coding sequences in the mouse: evolutionary relationships between the actin genes of warm-blooded vertebrates. J Mol Evol 23: 11-22, 1986.
36. Förster E: Rapid generation of internal standards for competitive PCR by low-stringency primer annealing. Biotechniques 16: 1006-1008, 1994.
37. Wadhwani KC, Fukuyama R, Giordano T, Rapoport SI and Chandrasekaran K: Quantitative reverse transcriptase-polymerase chain reaction of glucose transporter 1 mRNA levels in rat brain microvessels. Anal Biochem 215: 134-141, 1993.
38. Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K and Kishimoto T: Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 94: 2626-2632, 1996.
39. Akira S, Nishio Y, Inoue M, Wang X-J, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M and Kishimoto T: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77: 63-71, 1994.
40. Zhong Z, Wen Z and Darnell JE Jr: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95-98, 1994.
41. Megeney LA, Perry RL, LeCouter JE and Rudnicki MA: bFGF and LIF signaling activates STAT3 in proliferating myoblasts. Dev Genet 19: 139-145, 1996.
42. Carballo M, Conde M, El Bekay R, Martin-Nieto J, Camacho MJ, Monteseirin J, Conde J, Bedoya FJ and Sobrino F: Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 274: 17580-17586, 1999.
43. Hirota H, Yoshida K, Kishimoto T and Taga T: Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92: 4862-4866, 1995.
44. Pan J, Fukuda K, Kodama H, Makino S, Takahashi T, Sano M, Hori S and Ogawa S: Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res 81: 611-617, 1997.
45. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA and Hilton DJ: A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921, 1997.
46. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S and Kishimoto T: Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924-929, 1997.
47. Minamoto S, Ikegame K, Ueno K, Narazaki M, Naka T, Yamamoto H, Matsumoto T, Saito H, Hosoe S and Kishimoto T: Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem Biophys Res Commun 237: 79-83, 1997.
48. Erdmann J, Hassfeld S, Kallisch H, Fleck E and Regitz-Zagrosek V: Cloning and characterization of the 5'-flanking region of the human cardiotrophin-1 gene. Biochem Biophys Res Commun 244: 494-497, 1998.